2.58
0.78%
0.0199
Handel nachbörslich:
2.62
0.04
+1.55%
Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
14.90%
3.138
|
2.731 | 3.427 | 3.014 | 2.944 |
Cost Of Revenue |
3.62%
1.678
|
1.741 | 2.223 | 2.15 | 2.113 |
Gross Profit |
47.47%
1.46
|
0.99 | 1.204 | 0.864 | 0.831 |
Operating Expenses
|
4.82%
2.304
|
2.198 | 2.444 | 2.011 | 2.665 |
Benefits Costs and Expenses |
0.79%
4.061
|
4.029 | 4.878 | 4.453 | 4.849 |
Costs And Expenses |
0.79%
4.061
|
4.029 | 4.878 | 4.453 | 4.849 |
Operating Income/Loss |
30.13%
-0.844
|
-1.208 | -1.24 | -1.147 | -1.834 |
Income/Loss From Continuing Operations Before Tax |
28.89%
-0.923
|
-1.298 | -1.451 | -1.439 | -1.905 |
Income Tax Expense/Benefit, Deferred |
196.30%
-0.052
|
0.054 | 0.09 | - | - |
Income Tax Expense/Benefit |
130.65%
-0.057
|
0.186 | -0.033 | -0.131 | 0.034 |
Income/Loss From Continuing Operations After Tax |
41.64%
-0.866
|
-1.484 | -1.418 | -1.308 | -1.939 |
Net Income/Loss
|
41.64%
-0.866
|
-1.484 | -1.418 | -1.339 | -1.939 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | -0.031 | - |
Basic Average Shares |
211.15K%
10.91
|
0.00516 | 0.00494 | 0.00029 | 0.00311 |
Diluted Average Shares |
211.15K%
10.91
|
0.00516 | 0.00494 | 0.00029 | 0.00311 |
Basic Earnings Per Share |
72.41%
-0.08
|
-0.29 | -0.29 | -0.28 | -0.62 |
Diluted Earnings Per Share |
72.41%
-0.08
|
-0.29 | -0.29 | -0.28 | -0.62 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):